BN-52021


BN-52021

Ginkgolide B

Catalog:CDPE23-048-L

Unit Size:25 mg, 50 mg, 100 mg, 200 mg, 500 mg

INQUIRY Datasheet

Specifications
Common Use Ginkgolide B (BN-52021), an important active terpenoid from Ginkgo biloba leaves, is reported to increase cell viability and decrease cell apoptosis. IC50 value: Target: In vitro: Ginkgolide B (0.2 or 0.4 μg/ml) was added to the culture medium in vitro led to increases in cell viability and decreases in the number of hippocampal cells undergoing AAPH-induced apoptosis. Ginkgolide B caused a dose-related protection against dysrhythmias; the antiarrhythmic effect of ginkgolide B was comparable to that of diltiazem and superior to the activity of metoprolol. Ginkgolide B can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances. In vivo: Oral administration of ginkgolide B (2 mg/kg/day, p.o.) caused a significant increase in cell viability and a highly significant decrease in the numbers of both spontaneously occurring and AAPH-induced apoptoses
Structure BN-52021
Molecular Weight 424.4
Purity ≥98%
Molecular Formula C20H24O10
CAS No. 15291-77-7
Appearance Solid
Storage Powder: -20 °C, 3 years; 4 °C, 2 year. In solvent: -80 °C, 2 years; -20 °C, 1 year
Solubility Soluble in DMSO
Related Products
Products
Fill out the form below
to receive a quote

GET A QUOTE

  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © 2024 CD Bioparticles. All rights reserved.
0
Inquiry Basket
Inquiry